Global Antiviral Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Antiviral Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Antiviral drugs are medicines that decrease the ability of flu viruses to reproduce. when used as directed, antiviral drugs may help reduce the duration of flu.
Antiviral Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antiviral Drugs market is projected to reach US$ 51390 million in 2034, increasing from US$ 40870 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hepatitis Therapeutics and HIV/AIDS Therapeutics are the major drivers for the industry.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antiviral Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
Segment by Type
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antiviral Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antiviral Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antiviral Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Antiviral Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antiviral Drugs introduction, etc. Antiviral Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antiviral Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Antiviral Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Antiviral Drugs market is projected to reach US$ 51390 million in 2034, increasing from US$ 40870 million in 2022, with the CAGR of 3.3% during the period of 2024 to 2034. Demand from Hepatitis Therapeutics and HIV/AIDS Therapeutics are the major drivers for the industry.
In this market study, analysts have estimated the reverse transcriptase inhibitors to dominate the antiviral drugs market during the forecast period. These are compounds that are used to inhibit the reverse transcriptase enzyme. The capability of this enzyme to catalyze the process of conversion of viral RNA into DNA, to infect the healthy host cell and replicate it is the key contributor to the growth of this segment in the hiv treatment drugs market.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Antiviral Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Roche
Johnson & Johnson
Merck
Novartis
Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
AbbVie
Segment by Type
Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Immune System Modulators
Segment by Application
Hepatitis Therapeutics
HIV/AIDS Therapeutics
Herpes Therapeutics
Influenza Therapeutics
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Antiviral Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Antiviral Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Antiviral Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of Antiviral Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Antiviral Drugs introduction, etc. Antiviral Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Antiviral Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices